Kubilay Karsidag
Istanbul University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kubilay Karsidag.
Diabetic Medicine | 2009
Ceylan Makine; Çağatay Karşıdağ; Pinar Kadioglu; H Ilkova; Kubilay Karsidag; S. E. Skovlund; Frank J. Snoek; F. Pouwer
Aims A meta‐analysis concluded that depression is associated with poor glycaemic control in Type 2 diabetes (DM2). In DM2 patients with deteriorating glycaemic control, the initiation of insulin therapy is often postponed. The aim of the present study was to determine whether symptoms of depression and diabetes‐specific emotional distress are associated with a more negative appraisal of insulin therapy.
The Lancet Global Health | 2016
Victoria Miller; Salim Yusuf; Clara K. Chow; Mahshid Dehghan; Daniel J. Corsi; Karen Lock; Barry M. Popkin; Sumathy Rangarajan; Rasha Khatib; Scott A. Lear; Prem Mony; Manmeet Kaur; Viswanathan Mohan; Krishnapillai Vijayakumar; Rajeev Gupta; Annamarie Kruger; Lungiswa Tsolekile; Noushin Mohammadifard; Omar Rahman; Annika Rosengren; Alvaro Avezum; Andres Orlandini; Noorhassim Ismail; Patricio López-Jaramillo; Afzalhussein Yusufali; Kubilay Karsidag; Romaina Iqbal; Jephat Chifamba; Solange Martinez Oakley; Farnaza Ariffin
BACKGROUND Several international guidelines recommend the consumption of two servings of fruits and three servings of vegetables per day, but their intake is thought to be low worldwide. We aimed to determine the extent to which such low intake is related to availability and affordability. METHODS We assessed fruit and vegetable consumption using data from country-specific, validated semi-quantitative food frequency questionnaires in the Prospective Urban Rural Epidemiology (PURE) study, which enrolled participants from communities in 18 countries between Jan 1, 2003, and Dec 31, 2013. We documented household income data from participants in these communities; we also recorded the diversity and non-sale prices of fruits and vegetables from grocery stores and market places between Jan 1, 2009, and Dec 31, 2013. We determined the cost of fruits and vegetables relative to income per household member. Linear random effects models, adjusting for the clustering of households within communities, were used to assess mean fruit and vegetable intake by their relative cost. FINDINGS Of 143 305 participants who reported plausible energy intake in the food frequency questionnaire, mean fruit and vegetable intake was 3·76 servings (95% CI 3·66-3·86) per day. Mean daily consumption was 2·14 servings (1·93-2·36) in low-income countries (LICs), 3·17 servings (2·99-3·35) in lower-middle-income countries (LMICs), 4·31 servings (4·09-4·53) in upper-middle-income countries (UMICs), and 5·42 servings (5·13-5·71) in high-income countries (HICs). In 130 402 participants who had household income data available, the cost of two servings of fruits and three servings of vegetables per day per individual accounted for 51·97% (95% CI 46·06-57·88) of household income in LICs, 18·10% (14·53-21·68) in LMICs, 15·87% (11·51-20·23) in UMICs, and 1·85% (-3·90 to 7·59) in HICs (ptrend=0·0001). In all regions, a higher percentage of income to meet the guidelines was required in rural areas than in urban areas (p<0·0001 for each pairwise comparison). Fruit and vegetable consumption among individuals decreased as the relative cost increased (ptrend=0·00040). INTERPRETATION The consumption of fruit and vegetables is low worldwide, particularly in LICs, and this is associated with low affordability. Policies worldwide should enhance the availability and affordability of fruits and vegetables. FUNDING Population Health Research Institute, the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, AstraZeneca (Canada), Sanofi-Aventis (France and Canada), Boehringer Ingelheim (Germany and Canada), Servier, GlaxoSmithKline, Novartis, King Pharma, and national or local organisations in participating countries.
Canadian Medical Association Journal | 2014
Scott A. Lear; Koon K. Teo; Danijela Gasevic; Xiaohe Zhang; Paul Poirier; Sumathy Rangarajan; Pamela Seron; Roya Kelishadi; Azmi Mohd Tamil; Annamarie Kruger; Romaina Iqbal; Hani Swidan; Diego Gómez-Arbeláez; Rita Yusuf; Jephat Chifamba; V Raman Kutty; Kubilay Karsidag; Rajesh Kumar; Wei Li; Andrzej Szuba; Alvaro Avezum; Rafael Diaz; Sonia S. Anand; Annika Rosengren; Salim Yusuf
Background: Household devices (e.g., television, car, computer) are common in high income countries, and their use has been linked to obesity and type 2 diabetes mellitus. We hypothesized that device ownership is associated with obesity and diabetes and that these effects are explained through reduced physical activity, increased sitting time and increased energy intake. Methods: We performed a cross-sectional analysis using data from the Prospective Urban Rural Epidemiology study involving 153 996 adults from high, upper-middle, lower-middle and low income countries. We used multilevel regression models to account for clustering at the community and country levels. Results: Ownership of a household device increased from low to high income countries (4% to 83% for all 3 devices) and was associated with decreased physical activity and increased sitting, dietary energy intake, body mass index and waist circumference. There was an increased odds of obesity and diabetes with the ownership of any 1 household device compared to no device ownership (obesity: odds ratio [OR] 1.43, 95% confidence interval [CI] 1.32–1.55; diabetes: OR 1.38, 95% CI 1.28–1.50). Ownership of a second device increased the odds further but ownership of a third device did not. Subsequent adjustment for lifestyle factors modestly attenuated these associations. Of the 3 devices, ownership of a television had the strongest association with obesity (OR 1.39, 95% CI 1.29–1.49) and diabetes (OR 1.33, 95% CI 1.23–1.44). When stratified by country income level, the odds of obesity and diabetes when owning all 3 devices was greatest in low income countries (obesity: OR 3.15, 95% CI 2.33–4.25; diabetes: OR 1.97, 95% CI 1.53–2.53) and decreased through country income levels such that we did not detect an association in high income countries. Interpretation: The ownership of household devices increased the likelihood of obesity and diabetes, and this was mediated in part by effects on physical activity, sitting time and dietary energy intake. With increasing ownership of household devices in developing countries, societal interventions are needed to mitigate their effects on poor health.
Diabetes Research and Clinical Practice | 2002
Ilhan Satman; M.T Yılmaz; N Gürsoy; Kubilay Karsidag; Nevin Dinccag; T Ovalı; Ş Karadeniz; V Uysal; Z Buğra; A Ökten; S Devrim
Alström syndrome is a rare cause of diabetes mellitus. We studied two generations of a Turkish family in whom four members were affected by Alström syndrome. The natural course of the syndrome in three sisters was followed for 13 yr. The three sisters had short stature and truncal obesity, and developed complete blindness due to retinitis pigmentosa at 10, 5 and 13 yr of age. Two had sensorineural hearing loss and mild mental retardation, while the other developed diabetic ketoacidosis (DKA) at 14 yr and was treated with insulin from onset of diabetes. In the second case, diagnosis of diabetes was made by an OGTT at age 20 yr, and controlled with diet alone for 11 yr, then with a sulphonylurea for 2.5 yr, then with insulin. The third case developed acute hyperglycaemia at 20 yr, and required insulin from onset. Moreover, transitional features of impaired carbohydrate and fat metabolism (severe hyperinsulinaemia and insulin resistance progressing to islet beta cell failure, and hypertriglyceridaemia with fatty liver) were demonstrated, in accord with the literature. Previously unreported findings characteristic of nephro-uropathy with early-onset hypertension were also detected, and included in all cases proteinuria, glomerulopathy, and abnormal locations of the kidneys, narrowed uretero-renal junctions and dilated ureters.
Fertility and Sterility | 2000
Burak Hacıhanefioglu; Hakan Seyisoglu; Kubilay Karsidag; Koray Elter; Feridun Aksu; Temel Yilmaz; Ali Osman Gurol
OBJECTIVE To evaluate the influence of insulin resistance on the plasma total renin level in normotensive women with polycystic ovary syndrome (PCOS). DESIGN Prospective, controlled study. SETTING University hospital. PATIENT(S) Twenty-five normotensive women with PCOS were compared with 11 normotensive control women with regular cycles and no features of PCOS. INTERVENTION(S) Clinical, ultrasonographic, and hormonal findings were used to define PCOS. Insulin resistance was estimated by continuous infusion of glucose with model assessment in the early follicular phase. MAIN OUTCOME MEASURE(S) Plasma levels of total renin and angiotensin II and serum levels of gonadotropins, DHEAS, total T, free T, 17 alpha-hydroxyprogesterone, and PRL were determined. RESULT(S) Plasma concentrations of angiotensin II were similar in the PCOS group and the control group. The concentration of total renin in plasma was higher in women with PCOS than in healthy women independent of insulin resistance. The sensitivity and specificity of the plasma total renin level to diagnose women with PCOS were calculated as 80% and 71.4%, respectively. CONCLUSION(S) The plasma total renin level is higher in normotensive women with PCOS than in healthy women independent of insulin resistance.
Psychiatry and Clinical Neurosciences | 2001
Serpil Salman; Ahmet Sengül; Fatih Salman; Emel Özer; Gürsoy N; Sukru Hatun; Kubilay Karsidag; Nevin Dinccag; Ilhan Satman; Yilmaz Mt
We read with great interest the article by Wang et al.1 We would like to draw your attention to the results of our study which evaluated the impact of Marmara earthquakes (Turkey) on 17 August and 12 November 1999, on the quality of life (QoL) of our type 1 diabetic patients using the WHO Well Being Questionnaire (W-BQ). The study included a group of patients (n = 77; males 47%; age 24.2 ± 8.5 years) who had participated in a previous QoL study in October 1998 and they were affected by at least one of the quakes. For the new study, data were collected in the third month following the second quake and compared to results of the previous ones. In addition, metabolic control (HbA1c), body mass index and daily insulin requirement were assessed before and after earthquakes. In the meanwhile, the type of effect by the earthquake, socioeconomically and/or physically, was investigated via a questionnaire which was completed by the patients. According to our results,W-BQ scores were affected inversely by the quake. Mean total W-BQ score was decreased from 69 ± 13 to 44 ± 14 (P < 0.001). However, depression and anxiety scores increased significantly (prior and after the quake; 34 ± 14 vs 54 ± 13; P < 0.001 and 41 ± 18 vs 70 ± 19; P < 0.001, respectively). Our results also revealed the scores for positive well-being and energy decreased from 64 ± 21 to 36 ± 20 (P < 0.001) and from 73 ± 18 to 62 ± 20 (P = 0.008), respectively. When the data were compared before and after the quakes there was no difference for body mass index (23 ± 1.4 vs 23 ± 2.8 kg/m2). However, HbA1c (7.4 ± 1.5 vs 8.8 ± 2.5%; P < 0.001) and daily insulin requirement (0.58 ± 0.3 vs 0.75 ± 0.3 IU/kg per day; P < 0.001) were increased. Moreover, physical and/or socioeconomic impacts of the quake obtained from the questionnaire were not found to be changed in parallel to the psychological impact (DW-BQ scores) of the quake. Finally, we did not find any meaningful difference in W-BQ scores of the subgroups of those who were affected seriously or those who were affected minimally by the earthquake in terms of physical and socioeconomical levels. The fact may be explained by the limited number of injured people in the study cohort. Those who were not seriously affected still have a strong fear of a new quake.
BMC Medical Research Methodology | 2011
Vicky Lehmann; Ceylan Makine; Çağatay Karşıdağ; Pinar Kadioglu; Kubilay Karsidag; F. Pouwer
BackgroundDepression is a common co-morbid health problem in patients with diabetes that is underrecognised. Current international guidelines recommend screening for depression in patients with diabetes. Yet, few depression screening instruments have been validated for use in this particular group of patients. Aim of the present study was to investigate the psychometric properties of the Turkish version of the Centre for Epidemiologic Studies Depression Scale (CES-D) in patients with type 2 diabetes.MethodsA sample of 151 Turkish outpatients with type 2 diabetes completed the CES-D, the World Health Organization-Five Well-Being Index (WHO-5), and the Problem Areas in Diabetes scale (PAID). Explanatory factor analyses, various correlations and Cronbachs alpha were investigated to test the validity and reliability of the CES-D in Turkish diabetes outpatients.ResultsThe original four-factor structure proposed by Radloff was not confirmed. Explanatory factor analyses revealed a two-factor structure representing two subscales: (1) depressed mood combined with somatic symptoms of depression and (2) positive affect. However, one item showed insufficient factor loadings. Cronbachs alpha of the total score was high (0.88), as were split-half coefficients (0.77-0.90). The correlation of the CES-D with the WHO-5 was the strongest (r = -0.70), and supported concurrent validity.ConclusionThe CES-D appears to be a valid measure for the assessment of depression in Turkish diabetes patients. Future studies should investigate its sensitivity and specificity as well as test-retest reliability.
Neurological Sciences | 2009
Sevki Sahin; Sibel Karsidag; Sunay Ayalp; Ahmet Sengül; Onder Us; Kubilay Karsidag
Recent studies have shown that impaired glucose tolerance (IGT) is associated with dysfunction in the peripheral and autonomic nerves. The aim of this study was to determine the electrophysiological abnormalities of IGT. To determine electrophysiological abnormality in the large sensorimotor and sudomotor autonomic nerves with IGT patients, 43 patients and 34 healthy subjects have been studied. Subjective neuropathy symptoms, neurological examination and the electrophysiological findings were evaluated. When conduction of large somatic fibers only was evaluated, the ratio of electrophysiological abnormality was found to be 21%. In addition, where sympathetic skin response was evaluated the sudomotor autonomic abnormality ratio was 28% in upper extremities, 53% in lower extremities, and 16% in upper and lower extremities together. The percentages of abnormal electrophysiological parameters in different motor and sensory nerves were 39.5% in the peroneal motor nerve, 20.9% in the median motor and sural sensory nerves, 18.6% in the median sensory nerve, 16.3% in the tibial motor nerve, 14% in the ulnar sensory nerve, and 2.3% in the ulnar motor nerve. While distal motor latency was the most frequent abnormal parameter in the median and tibial motor nerves, the amplitude changes in the peroneal and ulnar motor nerves were also prominent. In sensory evaluation, the onset latency in the median-ulnar sensory nerves and the amplitude in the sural sensory nerve were found to be evident abnormalities.
Cardiovascular Psychiatry and Neurology | 2011
Elisabeth M.J. Huis In 'T Veld; Ceylan Makine; Arie Nouwen; Çağatay Karşıdağ; Pinar Kadioglu; Kubilay Karsidag; F. Pouwer
The Problem Areas in Diabetes (PAID) scale is a widely used self-report measure that can facilitate detection of diabetes-specific emotional distress in clinical practice. The aim of this study was to assess the factor structure and validity of the Turkish version of the PAID. A validation study was conducted among 154 patients with insulin-naïve type 2 diabetes. Participants completed the PAID, Centre for Epidemiological Studies Depression Scale (CES-D), Insulin Treatment Appraisal Scale (ITAS), and World Health Organization-Five Well-Being Index (WHO-5) questionnaires. Exploratory factor analyses yielded a 2-factor structure, identifying a 15-item “diabetes distress” factor and a 5-item “support-related issues” factor. The total PAID-score and the two dimensions were associated with higher levels of depression and poor emotional well-being. In the present study, the Turkish version of the PAID had satisfactory psychometric properties, however, the factorial structure was found to differ from factor solutions from other countries.
Diabetes Research and Clinical Practice | 1993
M. Temel Yilmaz; A.Sevim Devrim; Fikret Biyal; Ilhan Satman; Elif Arioǧlu; Nevin Dinccag; Kubilay Karsidag; İlgin Özden; Nuray Gürel; Fikret Sipahioǧlu; Gunseli Yilmaz
This prospective pilot study was undertaken to test the efficacy of oral methyl-prednisolone (MP) therapy at spontaneous remission phase of type 1 diabetes in intervening the course of the disease. Twenty-five type 1 diabetic patients who were classified as having a spontaneous remission (honeymoon) were divided into treatment and non-treatment groups on voluntary basis. Fifteen patients thus making up the treatment group (13 males and 2 females, mean age 23.8 +/- 6.2 years) received 0.7-1.0 mg/kg/day of MP p.o. for 2 weeks. The dose of the drug was then gradually diminished every week until 5 mg/day (approx. 0.1 mg/kg/day) and discontinued at 10 +/- 2 weeks. In case of hyperglycemia occurring in 12 of 15 patients due to the administration of steroid, insulin was used to normalize blood glucose levels (average 0.47 +/- 0.21 IU/kg/day). The non-treatment group (8 males and 2 females, mean age 21.8 +/- 8.9) did not receive any special medication or placebo except for insulin whenever necessary to regulate glycemia. Upon completion of protocol, all patients in treatment group displayed clinical remission with 10 still in non-insulin requiring remission for follow-up periods ranging between 16 and 91 months. The remaining 5 patients relapsed within 3-15 months of therapy. Other metabolic (including basal and stimulated C-peptide levels) and immunological indices that have spontaneously ameliorated with the occurrence of honeymoon were also maintained within normal range in the NIR patients. Meanwhile, natural remission in the non-MP-treated group terminated at 3.4 +/- 0.6 months with deterioration of all metabolic and immunological markers as well as increasing requirements for insulin. In conclusion, the spontaneous remission of the patients could be prolonged significantly by MP therapy as opposed to no therapy (P < 0.001). These results suggest that the spontaneous remission phase may be a crucial point of intervention in immunotherapy of type 1 diabetes and that randomized trials with MP at this particular phase would be worthwhile.